Biotinylated SARS-CoV-2 Spike RBD Gamma Variant

• Description:

  Biotinylated SARS-CoV-2 Spike RBD Gamma Variant_x000D_ Catalog number: B2010504_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 25 ug_x000D_ Molecular Weight or Concentration: 27 kDa_x000D_ Supplied as: Liquid Solution_x000D_ Applications: molecular component of many serological and antigenic assays for SARS-CoV-2 and its variants_x000D_ Storage: -20℃_x000D_ Keywords: Gamma Variant Spike, P1 Spike RBD, P1 RBD, biotin Gamma RBD_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ Download SARS-CoV-2 Brochure_x000D_ _x000D_ References:_x000D_ 1: Giovanetti M, Benedetti F, Campisi G, Ciccozzi A, Fabris S, Ceccarelli G,_x000D_ Tambone V, Caruso A, Angeletti S, Zella D, Ciccozzi M. Evolution patterns of_x000D_ SARS-CoV-2: Snapshot on its genome variants. Biochem Biophys Res Commun. 2021_x000D_ Jan 29;538:88-91._x000D_ _x000D_ 2: Tang JW, Tambyah PA, Hui DS. Emergence of a new SARS-CoV-2 variant in the UK._x000D_ J Infect. 2021 Apr;82(4):e27-e28._x000D_ _x000D_ 3: Tang JW, Toovey OTR, Harvey KN, Hui DDS. Introduction of the South African_x000D_ SARS-CoV-2 variant 501Y.V2 into the UK. J Infect. 2021 Apr;82(4):e8-e10._x000D_ _x000D_ 4: Groves DC, Rowland-Jones SL, Angyal A. The D614G mutations in the SARS-CoV-2_x000D_ spike protein: Implications for viral infectivity, disease severity and vaccine_x000D_ design. Biochem Biophys Res Commun. 2021 Jan 29;538:104-107._x000D_ _x000D_ 5: Priesemann V, Balling R, Brinkmann MM, Ciesek S, Czypionka T, Eckerle I,_x000D_ Giordano G, Hanson C, Hel Z, Hotulainen P, Klimek P, Nassehi A, Peichl A, Perc_x000D_ M, Petelos E, Prainsack B, Szczurek E. An action plan for pan-European defence_x000D_ against new SARS-CoV-2 variants. Lancet. 2021 Feb 6;397(10273):469-470._x000D_ _x000D_ 6: Blackstone NW, Blackstone SR, Berg AT. Variation and multilevel selection of_x000D_ SARS-CoV-2. Evolution. 2020 Oct;74(10):2429-2434._x000D_ _x000D_ 7: The Lancet Respiratory Medicine. Realising the potential of SARS-CoV-2_x000D_ vaccines-a long shot? Lancet Respir Med. 2021 Feb;9(2):117._x000D_ _x000D_ 8: Zhang Y, Xi H, Juhas M. Biosensing Detection of the SARS-CoV-2 D614G_x000D_ Mutation. Trends Genet. 2021 Apr;37(4):299-302._x000D_ _x000D_ 9: Castillo AE, Parra B, Tapia P, Lagos J, Arata L, Acevedo A, Andrade W, Leal_x000D_ G, Tambley C, Bustos P, Fasce R, Fernández J. Geographical Distribution of_x000D_ Genetic Variants and Lineages of SARS-CoV-2 in Chile. Front Public Health. 2020_x000D_ Sep 22;8:562615._x000D_ _x000D_ 10: Kannan S, Shaik Syed Ali P, Sheeza A. Evolving biothreat of variant SARS-_x000D_ CoV-2 - molecular properties, virulence and epidemiology. Eur Rev Med Pharmacol_x000D_ Sci. 2021 Jun;25(12):4405-4412. _x000D_ _x000D_ Products Related to Biotinylated SARS-CoV-2 Spike RBD Gamma Variant : SARS-CoV-2

• Short Description:

  Catalog Number: B2010504 (25 ug)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5

• Height :

  0.5